3,3',4'-trihydroxyflavone has been researched along with 3',4',7-trihydroxyflavone in 3 studies
Studies (3,3',4'-trihydroxyflavone) | Trials (3,3',4'-trihydroxyflavone) | Recent Studies (post-2010) (3,3',4'-trihydroxyflavone) | Studies (3',4',7-trihydroxyflavone) | Trials (3',4',7-trihydroxyflavone) | Recent Studies (post-2010) (3',4',7-trihydroxyflavone) |
---|---|---|---|---|---|
39 | 0 | 22 | 24 | 0 | 16 |
Protein | Taxonomy | 3,3',4'-trihydroxyflavone (IC50) | 3',4',7-trihydroxyflavone (IC50) |
---|---|---|---|
Poly [ADP-ribose] polymerase tankyrase-1 | Homo sapiens (human) | 0.6378 | |
Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 7.5429 | |
Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 2 | |
Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 6.52 | |
Poly [ADP-ribose] polymerase tankyrase-2 | Homo sapiens (human) | 0.8705 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bast, A; Haenen, GR; Hageman, JA; Menge, WM; van Acker, FA; van Der Vijgh, WJ | 1 |
Eom, S; Hwang, DS; Hyun, J; Jo, G; Lee, Y; Lim, Y; Park, JC; Woo, Y | 1 |
Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
3 other study(ies) available for 3,3',4'-trihydroxyflavone and 3',4',7-trihydroxyflavone
Article | Year |
---|---|
Synthesis of novel 3,7-substituted-2-(3',4'-dihydroxyphenyl)flavones with improved antioxidant activity.
Topics: Animals; Antioxidants; Flavonoids; Free Radical Scavengers; In Vitro Techniques; Lipid Peroxidation; Male; Microsomes, Liver; Rats; Rats, Wistar | 2000 |
Relationships between structures of hydroxyflavones and their antioxidative effects.
Topics: Antioxidants; Flavones; Flavonoids; Flavonols; Free Radical Scavengers; Models, Molecular; Quantitative Structure-Activity Relationship | 2010 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |